Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,312 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06336707RecruitingPhase 1
HS-20089 combination for advanced solid tumors
This trial tests a new combination treatment called HS-20089 for people with advanced solid tumors. The goal is to see if it is safe and how well it works against cancer that has not responded to other treatments.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06507683Recruiting
Radiation plus ripretinib for advanced GIST
This trial tests whether adding radiation therapy to the drug ripretinib can help people with advanced gastrointestinal stromal tumors (GIST) that can't be removed by surgery and have stopped responding to other treatments. It aims to see if this combination is safe and effective.
Chongqing, Chongqing MunicipalityAges 18–75 - NCT06515262Recruiting
Testing anti-BCMA-GPRC5D CAR-T cells for relapsed multiple myeloma
This trial tests a new type of cell therapy (CAR-T cells) that targets two proteins, BCMA and GPRC5D, on myeloma cells. It aims to see if it is safe and effective for people whose multiple myeloma has come back or stopped responding to at least three previous treatments.
Kunming, Kunming, YunnanAges 18–75 - NCT06511089RecruitingPhase 3
Carotid artery stenting during stroke clot removal
This trial tests whether placing a stent in a narrowed carotid artery during a procedure to remove a stroke clot improves outcomes. If you have a stroke with a blocked large artery and significant carotid narrowing, this study may be relevant to you.
GroningenAges 18 years+ - NCT05681988Recruiting
Minimally invasive endoscopic surgery for brain bleeding
This trial studies whether a minimally invasive, image-guided endoscopic procedure can remove blood after a specific type of brain bleed. It may help reduce symptoms and improve outcomes compared with standard care, but you must meet timing and medical criteria.
BaselAges 18–85 - NCT06005298Recruiting
Testing SBIRT to help with PrEP and alcohol use
This study looks at whether talking about alcohol use can help people stick with their PrEP routine. It tests a simple program called SBIRT (Screening, Brief Intervention, and Referral to Treatment) to support your health and HIV prevention.
Louisville, KentuckyAges 18–85 - NCT06503276RecruitingPhase 2
Orelabrutinib and radiation for a type of eye lymphoma
This trial tests a combination of a targeted drug (Orelabrutinib) and radiation therapy for adults newly diagnosed with a slow-growing lymphoma around the eye. The goal is to see if this approach works well and is safe for people who have not had treatment before.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06514118Recruiting
Immunotherapy with radiation for advanced small-cell lung cancer
This trial tests a combination of chemotherapy, immunotherapy, and targeted radiation for people with extensive-stage small-cell lung cancer. The goal is to see if adding radiation to leftover tumors after initial treatment helps control the disease better.
Qingdao, ShandongAges 18–80 - NCT06514560Recruiting
Optimizing miltefosine treatment for leishmaniasis patients
This trial tests how well miltefosine works for people with leishmaniasis, a skin infection from a parasite. It aims to find the best way to use this medicine to help patients get better.
Addis AbabaAges 2 years+ - NCT06514053Recruiting
Predicting success of molar pulp treatment
This study looks at whether certain signs in your tooth can help predict if a special type of filling (pulpotomy) will work for deep cavities in back teeth. It may help find the best treatment for you.
Hong KongAges Any age - NCT04807257RecruitingPhase 1/Phase 2
Targeted radiation for advanced skin tumors with a nano-therapy
This Phase 1/2 study tests an “Auger molecular therapy” treatment that uses targeted radiation on certain advanced cancers that have spread to the skin. It may help shrink or control skin tumors where the lesion size and location fit the treatment device.
TaipeiAges 18 years+ - NCT06517004RecruitingPhase 1
Study of JWCAR201 for relapsed or refractory large B-cell lymphoma
This trial tests a new cell therapy called JWCAR201 for people with a type of lymphoma (diffuse large B-cell lymphoma) that has come back or not responded to at least two prior treatments. The goal is to see if this treatment can help when standard options have stopped working.
ShanghaiAges 18 years+ - NCT07794839Recruiting
Drug-coated balloon treatment for heart artery blockages
This trial tests a special balloon that releases medicine to open blocked heart arteries. It may help people with chest pain or silent ischemia by keeping arteries open longer.
IstanbulAges Any age - NCT06517238Recruiting
Digital tool to improve dental care during braces treatment
This trial tests a new digital communication tool that helps your dentist and orthodontist work together better. The goal is to improve how your teeth are cared for while you have braces.
ReimsAges 8–18 - NCT07794891RecruitingPhase 4
Botox for jawline and neck lines
This study tests a cosmetic treatment using Botox to improve the appearance of neck lines and jawline definition. It aims to see how satisfied participants are with the results after treatment.
Vancouver, British ColumbiaAges 22–65 - NCT06285721Recruiting
Brain stimulation for treating delirium
This trial tests if a gentle electrical brain stimulation (tACS) can help treat delirium. If you are over 50 and have had delirium for at least two days, you may be eligible.
Nijmegen, GelderlandAges 50 years+ - NCT03676504RecruitingPhase 1/Phase 2
CAR T cell therapy for relapsed CD19 blood cancers
This trial tests a type of personalized immune treatment (CD19 CAR T cells made from your T cells) for adults (and children with ALL) whose CD19-positive blood cancer has come back or didn’t respond. It may help your immune system recognize and attack cancer cells that still have CD19.
HeidelbergAges 3 years+ - NCT07792746Recruiting
Sleep apnea markers and use of CPAP therapy
This study looks at whether certain markers in sleep apnea patients can predict how well they will stick with CPAP (a mask that helps you breathe at night). If you're newly diagnosed and about to start CPAP, this could help personalize your care.
MontpellierAges 18 years+ - NCT07799818Recruiting
Joint replacement study for hip or knee
This study looks at how well hip or knee replacements work. If you are already scheduled for a replacement or a revision (a second replacement), you may be able to join.
Bonn, North Rhine-WestphaliaAges 18–100 - NCT07796217RecruitingPhase 4
Comparing blood thinners after a heart attack
This study compares two ways to lower the chances of another heart attack: taking the standard medicine (clopidogrel) versus taking a combination of aspirin and a lower dose of a blood thinner (rivaroxaban). If you join, you'll be assigned to one of these options to see which works better for people like you.
Seongnam-si, Gyeonggi-doAges 19 years+ - NCT07798960RecruitingPhase 2
Light therapy for diabetic foot ulcers
This study tests whether shining a special light on diabetic foot ulcers can help them heal faster. It aims to find out if the treatment is safe and effective.
Teresina, PiauíAges 18 years+ - NCT07793799Enrolling by invitation
Comparing brain stimulation treatments for swallowing problems after stroke
This study tests three non-invasive brain stimulation methods to see if they can help improve swallowing after a stroke. If you have swallowing difficulties due to a stroke, this research might offer a new way to support your recovery.
IstanbulAges 18 years+ - NCT07795502Recruiting
Tracking infections in cancer patients with sepsis
This study watches how infections grow and respond to treatment in cancer patients who may have sepsis. It aims to find better ways to diagnose and monitor sepsis early, which could improve care and outcomes.
Sohag, Sohag GovernorateAges 18 years+ - NCT07796516RecruitingPhase 2
Telitacicept for difficult-to-treat rheumatoid arthritis
This trial tests if a new medication, telitacicept, is safe and effective for people with difficult-to-treat rheumatoid arthritis. It may be an option for patients who have not found relief from other treatments.
Hefei, AnhuiAges 18 years+
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,312 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.